secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001104659-26-009747
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics posts updated corporate presentation on website
-----------------------------------------------------------------

- Presentation filed as Exhibit 99.1 on Form 8-K dated February 3, 2026.
- Slides describe business overview; only cover page and disclaimer are in filed text.
- No financial results, pipeline updates, or guidance disclosed in the exhibit.
- Investor presentation routine; no material new information provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/0001104659-26-009747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/tm265021d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-009747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer